EUVIMEDEUVIMED entdecken
Crossref

Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan

Yoshimi Kiyozumi iD, Seiichiro Nishimura, Nobuhiro Kado, Satomi Higashigawa, Yasue Horiuchi, Eiko Ishihara, Rina Harada, Hiroyuki Matsubayashi iD

Journal of Genetic Counseling · 2025

DOI: 10.1002/jgc4.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2025. Verfasst von Yoshimi Kiyozumi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: Genetic Testing, Germ-Line Mutation, BRCA1 Protein, BRCA2 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical management for hereditary cancer patients, risk assessment is needed not only for patients but also for their blood relatives. In people with Hereditary Breast and Ovarian Cancer syndrome (HBOC), benefits are demonstrated by identifying relatives with BRCA1 and BRCA2 pathogenic germline variants (PGV) and implementing clinical surveillance and risk‐reduction surgeries for the at‐risk organs. To date, the uptake of cascade testing has been reported to be insufficient, but only a limited number of studies have analyzed the barriers to cascade testing. The current study aimed to analyze the uptake of cascade testing in the relatives of Japanese HBOC probands and clarify the factors that promote cascade testing uptake. This retrospective study included 125 probands carrying BRCA1 or BRCA2 PGV and 425 of their first‐degree relatives (FDRs). Individual clinicodemographic data were collected from medical records, and comparisons were made between those who did and did not undergo cascade testing. Ninety‐two (21.6%) FDRs of HBOC probands underwent cascade testing. Approximately 70% of the relatives underwent testing within 6 months of the proband's genetic testing. Independent predictors of cascade testing of 425 FDRs were: being present at the proband's genetic counseling session [odds ratio (OR): 8.3, 95% CI 4.2–16.1], cost‐free testing (OR: 2.4, 95% CI 1.4–4.2), being the child of a proband (OR: 1.9, 95% CI 1.1–3.2), and female sex (OR: 1.8, 95% CI 1.0–3.0). The cascade testing uptake rate of FDRs in this study was similar to or lower than other countries. cascade testing uptake can be improved in HBOC families by encouraging relatives (children, siblings, and parents) to attend genetic counseling with the proband. Further prospective studies are needed to pursue the reasons for accepting cascade testing, including an evaluation of intrafamily communication processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGerm-Line MutationBRCA1 ProteinBRCA2 ProteinHereditary Breast and Ovarian Cancer SyndromeHumansFemaleJapanMaleMiddle AgedAdultRetrospective StudiesGenetic CounselingGenetic Predisposition to Disease

Stichwörter der Autor:innen

HBOCcascade testinggenetic counselingpredictive factor

Substanzen

BRCA1 protein, humanBRCA1 ProteinBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Breast Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

ORCID-Profile: Yoshimi Kiyozumi, Hiroyuki Matsubayashi

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kiyozumi, Y., Nishimura, S., Kado, N., Higashigawa, S., Horiuchi, Y., Ishihara, E., Harada, R., & Matsubayashi, H. (2025). Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.70055

Vancouver

Kiyozumi Y, Nishimura S, Kado N, Higashigawa S, Horiuchi Y, Ishihara E, et al. Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan. Journal of Genetic Counseling. 2025. doi:10.1002/jgc4.70055

BibTeX
@article{Kiyozumi2025,
  author = {Kiyozumi, Yoshimi and Nishimura, Seiichiro and Kado, Nobuhiro and Higashigawa, Satomi and Horiuchi, Yasue and Ishihara, Eiko and Harada, Rina and Matsubayashi, Hiroyuki},
  title = {Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan},
  journal = {Journal of Genetic Counseling},
  year = {2025},
  doi = {10.1002/jgc4.70055}
}
Kostenlos starten →